Julie Leask

Last updated

Julie Leask
AO
OccupationSocial scientist
Employer University of Sydney
Known forVaccine research
TitleProfessor

Julie Leask AO , also known as Julie-Anne Leask, is an Australian social scientist and professor in the School of Public Health and Sydney Infectious Diseases Institute at the University of Sydney, Australia. [1] [2] She is a leading researcher on social and behavioural aspects of vaccination and infectious disease prevention. [3] Leask's research focuses on vaccine uptake, communication, strengthening vaccination programs and policy. [1]  Her flagship project is Sharing Knowledge About Immunisation (SKAI), a vaccination communication package designed to improve vaccination conversations between parents and health care workers. [4] Additionally, Leask is an advisor to the World Health Organization (WHO) on vaccine acceptance and demand issues and was the chair of the WHO Measuring Behavioural and Social Drivers of Vaccination working group (2018–2022). [1] [5] [6]

Contents

Education

Leask holds a Diploma in Health Science (Nursing) from the University of Technology Sydney (1990), a Certificate of Midwifery Theory and Practice from the Northern Sydney Area Midwifery School (1992), a Master of Public Health from the University of Sydney (1998) and a Doctor of Philosophy (Ph.D.) also from the University of Sydney (2002). Her Ph.D. thesis was titled Understanding Immunisation Controversies. [7] [8] [9]

Professional academic life

Leask's Masters treatise in 1997 described the major themes in anti-vaccination reporting in the Australian print media. [1] After completing her Ph.D. in 2002, Leask established the Social Science Unit at the National Centre for Immunisation Research and Surveillance. [10] In 2012, she was appointed as an NHMRC Career Development Fellow at the School of Public Health, University of Sydney. In 2017, she moved to the Susan Wakil School of Nursing and Midwifery, Faculty of Medicine and Health, The University of Sydney, becoming Professor in 2018. She is Visiting Professorial Fellow at the National Centre for Immunisation Research and Surveillance. She currently co-leads the Social and Behavioural Insights in Immunisation research group at the University of Sydney [11]   - a team of postdoctoral researchers, research assistants, and higher degree research students. [1]

Research and impact

Leask's research and impact extend over more than two decades. Her research centres around: (1) identifying the causes of low vaccination with quality data; (2) synthesising and translating evidence for raising vaccination rates; (3) building the capacity of researchers, practitioners, and program managers in closing coverage gaps and improving program delivery; and (4) improving public communication in health emergencies. [1] [12]

Leask led the development of Sharing Knowledge About Immunisation (SKAI) - a vaccination communication package designed to improve vaccination conversations between parents and healthcare workers. SKAI provides communication strategies, tailored resources, a website, and a training module. SKAI was implemented nationally in Australia through the National Centre for Immunisation Research and Surveillance. [4]

Leask's current focus is on global tools to diagnose and act on the causes of low vaccination. [13] [14] Her chairing role with WHO focused on quality measures of the reasons for the under-vaccination of children and COVID-19 vaccination in adults and healthcare workers. These surveys and interview guides measure the Behavioural and Social Drivers of Vaccination (BeSD) within the domains of (1) Thinking and feeling about vaccines; (2) Social processes that drive or inhibit vaccination; (3) Motivation (or hesitancy) to seek vaccination; and (4) Practical issues involved in seeking and receiving a vaccination. These tools are now being used in multiple countries to determine barriers to routine immunisation. [1] [6]

International expert contributions

Leask's international expert contributions to vaccination include the World Health Organization (WHO), UNICEF, International Federation for the Red Cross and Red Crescent Societies, US Centre for Diseases Control and Prevention, and the US President's Cancer Panel. She has held international advisory roles with the WHO working group for measuring the Behavioural and Social Drivers of Vaccination (Chair 2018–2022) [6] ; the WHO Immunization and Vaccines related Implementation Research advisory committee (2019-2023); the WHO South East Asia Region Immunisation Technical Advisory Group (2020-2023); and was the lead guidance writer for the COVID-19 vaccine safety communication manual for the WHO Global Advisory Committee of Vaccine Safety. She was a co-author on a commissioned review paper on increasing vaccination uptake for Psychological Sciences in the Public Interest. [1]

Publications

Leask has over 145 publications, as at July 2024. [15] Select publications include the following:

Awards and honours

Related Research Articles

<span class="mw-page-title-main">Vaccination</span> Administration of a vaccine to protect against disease

Vaccination is the administration of a vaccine to help the immune system develop immunity from a disease. Vaccines contain a microorganism or virus in a weakened, live or killed state, or proteins or toxins from the organism. In stimulating the body's adaptive immunity, they help prevent sickness from an infectious disease. When a sufficiently large percentage of a population has been vaccinated, herd immunity results. Herd immunity protects those who may be immunocompromised and cannot get a vaccine because even a weakened version would harm them. The effectiveness of vaccination has been widely studied and verified. Vaccination is the most effective method of preventing infectious diseases; widespread immunity due to vaccination is largely responsible for the worldwide eradication of smallpox and the elimination of diseases such as polio and tetanus from much of the world. However, some diseases, such as measles outbreaks in America, have seen rising cases due to relatively low vaccination rates in the 2010s – attributed, in part, to vaccine hesitancy. According to the World Health Organization, vaccination prevents 3.5–5 million deaths per year.

<span class="mw-page-title-main">Vaccine hesitancy</span> Reluctance or refusal to be vaccinated or have ones children vaccinated

Vaccine hesitancy is a delay in acceptance, or refusal, of vaccines despite the availability of vaccine services and supporting evidence. The term covers refusals to vaccinate, delaying vaccines, accepting vaccines but remaining uncertain about their use, or using certain vaccines but not others. Although adverse effects associated with vaccines are occasionally observed, the scientific consensus that vaccines are generally safe and effective is overwhelming. Vaccine hesitancy often results in disease outbreaks and deaths from vaccine-preventable diseases. Therefore, the World Health Organization characterizes vaccine hesitancy as one of the top ten global health threats.

<span class="mw-page-title-main">HPV vaccine</span> Class of vaccines against human papillomavirus

Human papillomavirus (HPV) vaccines are vaccines that prevent infection by certain types of human papillomavirus (HPV). Available HPV vaccines protect against either two, four, or nine types of HPV. All HPV vaccines protect against at least HPV types 16 and 18, which cause the greatest risk of cervical cancer. It is estimated that HPV vaccines may prevent 70% of cervical cancer, 80% of anal cancer, 60% of vaginal cancer, 40% of vulvar cancer, and show more than 90% effectiveness in preventing HPV-positive oropharyngeal cancers. They also protect against penile cancer. They additionally prevent some genital warts, with the quadrivalent and nonavalent vaccines that protect against HPV types HPV-6 and HPV-11 providing greater protection.

Viera Scheibner is a Slovak-Australian anti-vaccination activist and retired geologist. From 1958 until 1968 she was assistant professor in the department of geology at Comenius University, Bratislava. Since her retirement from the Department of Mineral Resources, New South Wales, Australia in 1987, Scheibner has been active in the anti-vaccination field, writing and giving lectures opposing vaccines and vaccinations.

The Joint Committee on Vaccination and Immunisation (JCVI) is an independent expert advisory committee that advises United Kingdom health departments on immunisation, making recommendations concerning vaccination schedules and vaccine safety. It has a statutory role in England and Wales, and health departments in Scotland and Northern Ireland may choose to accept its advice.

A vaccination policy is a health policy adopted in order to prevent the spread of infectious disease. These policies are generally put into place by state or local governments, but may also be set by private facilities, such as workplaces or schools. Many policies have been developed and implemented since vaccines were first made widely available.

The Australian Vaccination-risks Network Inc., formerly known as the Australian Vaccination-Skeptics Network (AVsN), and before that known as the Australian Vaccination Network (AVN), is an Australian anti-vaccination pressure group registered in New South Wales. As Australia's most controversial anti-vaccination organisation, it has lobbied against a variety of vaccination-related programs, downplayed the danger of childhood diseases such as measles and pertussis, championed the cause of alleged vaccination victims, and promoted the use of ineffective alternatives such as homeopathy.

<span class="mw-page-title-main">Judy Wilyman</span> Australian anti-vaccination activist

Roslyn Judith "Judy" Wilyman is an Australian anti-vaccination activist who came to prominence following the controversial award of a humanities PhD titled "A critical analysis of the Australian government's rationale for its vaccination policy" by University of Wollongong. The thesis came under heavy criticism from multiple directions, including medical professionals, due to claims within the thesis, including advancing a conspiracy theory whereby the World Health Organization (WHO) and the pharmaceutical industry supposedly conspire to promote vaccinations in the absence of evidence of safety and efficacy. The awarding of the degree created questions about the standards being applied and whether or not the thesis supervisors and examiners had sufficient knowledge to oversee the research, and led to calls for the university to review the doctorate. A number of individuals and medical organisations – including academics and researchers from other parts of the University of Wollongong – spoke out against the findings of the thesis, emphasising the need for vaccinations in order to prevent serious disease; and the University of Wollongong was criticised for a perceived lack of transparency in their doctoral process and an alleged failure to uphold standards of scholarship.

No Jab No Pay is an Australian policy initiative which withholds three state payments – Child Care Benefit, the Child Care Rebate and a portion of the fortnightly Family Tax Benefit part A per child – for parents of children under 20 years of age who are not fully immunised or on a recognised catch-up schedule. No Jab No Play is a related policy that disallows unvaccinated children from attending preschool and childcare centres, and imposes fines on childcare centres that admit unvaccinated children. The system allows exemptions for children who cannot be safely vaccinated for medical reasons.

Anti-vaccinationism in chiropractic is widespread, but there are notable differences within the trade. Chiropractic is a form of alternative medicine founded on the idea that all disease is caused by disruption of the flow of "innate" in the spine, by so-called vertebral subluxations – a pseudoscientific concept. Over time chiropractic has divided into "straights" who adhere to the subluxation theory and "mixers" who adhere more closely to a reality-based view of anatomy. "Straight" chiropractors are very likely to be anti-vaccination, but all chiropractic training tends to reduce acceptance of vaccines.

Nicola Mary Turner is a New Zealand public health advocate who is a Professor at the University of Auckland and Medical Director of the Immunisation Advisory Centre, an organisation that advises the New Zealand medical profession and the New Zealand Government. She has contributed to advisory committees for the New Zealand Ministry of Health, is a spokesperson for the Child Poverty Action Group and works in general practice. Much of her research and outreach has focused on improving immunisation coverage and closing equity gaps for the national schedule vaccine delivery in New Zealand and she has commented publicly on these issues during COVID-19 in New Zealand.

Sir Andrew John Pollard is the Ashall Professor of Infection & Immunity at the University of Oxford and a Fellow of St Cross College, Oxford. He is an Honorary Consultant Paediatrician at John Radcliffe Hospital and the Director of the Oxford Vaccine Group. He is the Chief Investigator on the University of Oxford COVID-19 Vaccine trials and has led research on vaccines for many life-threatening infectious diseases including typhoid fever, Neisseria meningitidis, Haemophilus influenzae type b, streptococcus pneumoniae, pertussis, influenza, rabies, and Ebola.

Helen Aspasia Petousis-Harris is a New Zealand vaccinologist and associate professor in the Department of General Practice and Primary Health Care at the University of Auckland. She has been involved in research related to vaccination in New Zealand since 1998, with her main areas of focus being vaccine safety and effectiveness. Petousis-Harris has had a variety of lead roles in New Zealand and international organisations that focus on vaccination and is a regular media spokesperson in this field, especially during the COVID-19 pandemic.

<span class="mw-page-title-main">COVID-19 vaccination in the United Kingdom</span> Immunisation against COVID-19

The COVID-19 vaccination programme in the United Kingdom is an ongoing mass immunisation campaign for coronavirus disease 2019 (COVID-19) during the COVID-19 pandemic in the United Kingdom.

Misinformation related to immunization and the use of vaccines circulates in mass media and social media in spite of the fact that there is no serious hesitancy or debate within mainstream medical and scientific circles about the benefits of vaccination. Unsubstantiated safety concerns related to vaccines are often presented on the internet as being scientific information. A large proportion of internet sources on the topic are mostly inaccurate which can lead people searching for information to form misconceptions relating to vaccines.

The Immunisation Advisory Centre (IMAC) is a New Zealand-wide organisation which provides information and training about immunization and vaccine-preventable diseases to health care professionals, government bodies, and individuals. It co-ordinates the nation's immunisation programmes, policy advice and research. It was launched in 1997, and is based at The University of Auckland.

The Australian Technical Advisory Group on Immunisation (ATAGI) is a technical advisory group of the Australian Government. As part of the Department of Health, ATAGI provides advice to the Minister of Health on the immunisation program of Australia and related matters, including the strength of evidence pertaining to existing, new, and emerging vaccines.

<span class="mw-page-title-main">The Green Book (immunisation guidance, UK)</span> Book about vaccination

Immunisation against infectious disease, popularly known as The Green Book, provides information on vaccines for vaccine-preventable diseases. It acts as a guide to the UK's vaccination schedule for health professionals and health departments that give vaccines in the United Kingdom.

Helen Siobhan Marshall is an Australian medical researcher who is Professor of Vaccinology at the University of Adelaide. She was named the South Australian of the Year for 2022.

<span class="mw-page-title-main">19 to Zero</span> Canadian communications initiative

19 to Zero is a not-for-profit behavioural sciences initiative based in Calgary, Alberta, Canada. Hosted at the University of Calgary, the public–private partnership is made up of around 500 members including public health specialists, academics, behavioural psychologists, marketers and multimedia creators. Its purpose is to increase confidence in vaccines for COVID-19 and other diseases by tackling vaccine hesitancy. The group publishes materials on its website and through partner organizations, including videos, billboards, presentations, brochures and in-person events.

References

  1. 1 2 3 4 5 6 7 8 9 10 11 12 13 14 "Staff Profile". The University of Sydney. Retrieved 5 August 2024.
  2. "Julie Leask". The Sydney Morning Herald. 1 August 2022. Retrieved 24 July 2024.
  3. "RACGP".
  4. 1 2 "Our Team". Sharing Knowledge About Immunisation. Retrieved 5 August 2024.
  5. "It's not just vaccine refusers who might not get the COVID-19 vaccination". The University of Sydney. Retrieved 7 July 2022.
  6. 1 2 3 World Health Organization (2022). Behavioural and social drivers of vaccination: tools and practical guidance for achieving high uptake. World Health Organization. ISBN   978-92-4-004968-0.
  7. "Professor Julie Leask". The University of Sydney. Retrieved 9 November 2022.
  8. "Julie Leask". The Conversation. Retrieved 7 April 2022.
  9. Leask, J (1 January 2002). Understanding Immunisation Controversies (PhD thesis).
  10. "Affiliates | NCIRS". ncirs.org.au. Retrieved 16 February 2023.
  11. "SABII". SABII: Social and Behavioural Insights in Immunisation. 5 August 2024. Retrieved 5 August 2024.
  12. "Julie Leask". The Conversation. 22 December 2022. Retrieved 24 July 2024.
  13. "Why some over-50s aren't booking in for vaccine despite TGA advice". ABC News. 20 May 2021. Retrieved 24 July 2024.
  14. "newsGP - Almost 30% of Australians unsure about COVID vaccine – and that's where GPs come in". NewsGP. Retrieved 24 July 2024.
  15. "ORCID". orcid.org. Retrieved 24 July 2024.
  16. Robinson, Penelope; Degeling, Chris; Wiley, Kerrie; Carter, Stacy; Leask, Julie (3 June 2024). "Evidence gaps and challenges in maintaining and increasing vaccine uptake: A Delphi survey with Australian stakeholders". Health Promotion Journal of Australia. doi: 10.1002/hpja.875 . ISSN   1036-1073.
  17. Leask, Julie; Seale, Holly; Williams, Jane H; Kaufman, Jessica; Wiley, Kerrie; Mahimbo, Abela; Clark, Katrina K; Danchin, Margie H; Attwell, Katie (13 December 2021). "Policy considerations for mandatory COVID‐19 vaccination from the Collaboration on Social Science and Immunisation". Medical Journal of Australia. 215 (11): 499–503. doi:10.5694/mja2.51269. ISSN   0025-729X. PMC   8661777 . PMID   34510461.
  18. Carlson, Samantha J; Blyth, Christopher C; Beard, Frank H; Hendry, Alexandra J; Cheng, Allen C; Quinn, Helen E; Leask, Julie; Macartney, Kristine (19 July 2021). "Influenza disease and vaccination in children in Australia". Medical Journal of Australia. 215 (2): 64. doi:10.5694/mja2.51100. ISSN   0025-729X.
  19. "Professor Julie-Anne Elizabeth Leask". Australian Honours Search Facility. Retrieved 25 January 2024.
  20. "APNA" . Retrieved 5 August 2024.
  21. "Women of Influence". Australian Financial Review. Retrieved 7 April 2022.
  22. "Pacific Health Security". DFAT. Australian Government.
  23. "Julie Leask". behaviouraleconomics.pmc.gov.au. Retrieved 9 July 2022.
  24. Leask, Julie (15 August 2015). "The Rewards and Challenges of Academic Supervision - Associate Professor Julie Leask".

Further reading